inherited metabolic disease of liver epidemology in india
inherited metabolic liver disease India epidemiology
inherited metabolic liver disease epidemiology India prevalence incidence 2022 2023 2024
Wilson disease India prevalence epidemiology
lysosomal storage disorder India epidemiology Gaucher Niemann
inborn errors metabolism liver India children
hereditary metabolic liver disease India registry newborn screening
Wilson disease India ATP7B mutation spectrum
glycogen storage disease Gaucher India prevalence
PMID: 39535360
PMID: 36112267
alpha-1 antitrypsin deficiency India prevalence epidemiology
lysosomal storage diseases India incidence newborn screening
PMID: 39138584
Wilson disease India prevalence 1 in 18000 lysosomal storage Gaucher Niemann Pick glycogen storage disease epidemiology Indian subcontinent
Inherited Metabolic Diseases of the Liver - Epidemiology in India
Why India Has a Higher Burden
- Consanguinity: An estimated 20-50% of marriages in South India, Rajasthan, Gujarat, and Muslim communities are consanguineous. This dramatically increases homozygosity for rare autosomal recessive mutations.
- Endogamous population structure: India has ~4,600 population groups, thousands of which are endogamous. This allows founder mutations to propagate within communities (e.g., Gaucher disease in Maharashtra, Tay-Sachs in Gujarat).
- Underdiagnosis: Limited newborn screening, lack of specialized metabolic centers, and high out-of-pocket costs mean IMLDs are commonly missed or diagnosed late.
- Large absolute population: Even a "rare" incidence of 1:10,000 translates to 140,000 affected individuals nationally.
Disease-by-Disease Epidemiology
1. Wilson Disease (Hepatolenticular Degeneration)
- Global incidence: ~1 in 30,000-40,000 live births; carrier rate ~1 in 90-180 (Goldman-Cecil Medicine).
- India-specific prevalence: A landmark 2025 pan-India multicenter genomic study (Kumar et al., PMID: 39535360) of 128 clinically diagnosed WD patients found:
- Prevalence in India: 1 in 18,678 (significantly higher than the global estimate of 1 in 30,000-40,000)
- Carrier rate in India: 1 in 67 (vs. global estimate of 1 in 90-180)
- India often goes undiagnosed due to absence of systematic screening; WD often presents as chronic liver disease or neuropsychiatric symptoms and is missed.
- There is marked genetic heterogeneity in Indian patients, with no single predominant ATP7B mutation across the country, reflecting the ethnic diversity of the Indian population (Nagral et al., PMID: 36112267).
- 22 novel ATP7B variants identified in Indian cohorts in the 2025 study.
2. Lysosomal Storage Disorders (LSDs) - Including Hepatic Forms
a. Gaucher Disease (most common LSD with liver involvement in India)
- Most common LSD in India, constituting up to 16% of all LSD cases from single-centre data (Sheth et al.) and 46.1% of pediatric LSD cases in some regional (Rajasthan) studies.
- Global incidence: 1 in 40,000-60,000 live births; carrier frequency 1 in 14 in Ashkenazi Jews, but India's precise incidence is unknown.
- Presents with hepatosplenomegaly, cytopenia, anemia - all signs of hepatic infiltration.
- Predominant Indian mutation: L444P (c.1448T>C in GBA gene) - seen in 60% of pan-India patients (Sheth et al.) - different from the N370S predominant in Ashkenazi Jewish patients.
- Higher prevalence noted in Maharashtra and among the Mappila Muslim community of Kerala (founder effect).
- Type III (neuronopathic) form relatively more common in India than in Western cohorts.
b. Niemann-Pick Disease Type A/B (sphingomyelinase deficiency, hepatosplenomegaly)
- Second most common LSD with hepatic involvement in India.
- Predominant mutations in India: p.R542* (21.7%) and p.R418* (6.6%) - from the DHR-ICMR National Task Force for LSDs study (60 families).
- Type C confirmed by fibroblast filipin staining.
c. GM2 Gangliosidoses (Tay-Sachs and Sandhoff Disease)
- Together 17.8% of LSDs in India (Tay-Sachs 10%, Sandhoff 7.8%) in some series.
- Tay-Sachs founder variant identified in Gujarat province.
- Predominantly neurodegenerative, though hepatomegaly can occur.
d. Mucopolysaccharidoses (MPS)
- Second-most common group of LSDs in India (~22% of LSDs in India).
- MPS I (Hurler syndrome - associated with hepatosplenomegaly): Predominant mutations p.Arg619* (25%) and p.Ala75Thr (20%) in Indian patients.
- MPS IVA (Morquio): Founder variant identified in India.
3. Glycogen Storage Diseases (GSDs)
- GSDs account for ~5% of LSD-type conditions in Indian pediatric studies.
- GSD Type Ia (Von Gierke) and GSD Type III are the most common forms with hepatic involvement.
- No large Indian epidemiological registry exists; most data comes from case series. Estimated global incidence of GSDs is ~1 in 20,000-25,000 live births.
- Indian data suggests higher frequency in communities with consanguinity.
4. Hereditary Hemochromatosis (HFE-related)
- Classic HFE hemochromatosis (C282Y mutation) is predominantly a disease of Northern European ancestry (carrier rate ~1 in 10 in Celts/Irish).
- The C282Y allele is very rare in India and South Asia; classic hereditary hemochromatosis is correspondingly rare.
- However, non-HFE iron overload states (including juvenile hemochromatosis, ferroportin disease) have been reported in Indian patients, often misclassified.
- Clinically significant iron overload in India is more commonly secondary (transfusions, hemolytic anemias like thalassemia) rather than primary hereditary hemochromatosis.
5. Alpha-1 Antitrypsin Deficiency (A1ATD)
- Globally, the second most common metabolic disease affecting the liver (after hereditary hemochromatosis), with 1 in 2,000-5,000 live births (mainly in Northern European populations) - Sleisenger & Fordtran.
- The Z allele (PI*Z) causing severe deficiency is very uncommon in India. A 2022 systematic review (PMID: 35321931) confirms India has very low burden of A1AT deficiency.
- Rare case reports of A1ATD liver disease do exist from India, and the diagnosis is chronically underrecognized.
6. Urea Cycle Disorders (UCDs)
- UCDs (ornithine transcarbamylase deficiency being the most common) present with acute liver dysfunction and hyperammonemia in neonates/infants.
- Indian-specific epidemiology is poorly documented; case series from NIMHANS and AIIMS suggest these are more common than diagnosed.
- Consanguinity greatly increases risk for autosomal recessive UCDs.
7. Other Notable IMLDs in India
| Disease | India Relevance |
|---|---|
| Progressive familial intrahepatic cholestasis (PFIC) | Increasing case reports; underdiagnosed |
| Primary hyperoxaluria | Reports from Kashmir (PMID: 37803380); often presents with oxalate deposits in liver/kidney |
| Neonatal hemochromatosis | Gestational alloimmune liver disease; case series from India |
| Tyrosinemia Type I | Rare; presents with acute liver failure in infants |
| Galactosemia | No national screening; estimated incidence 1:40,000-1:60,000 |
| Porphyrias | Case reports from India (PMID: 37082991); often masquerade as common diseases |
Key Determinants of India's IMLD Burden
- No universal newborn screening (NBS): India lacks a nationwide NBS program for IEM. A few states (Tamil Nadu, Maharashtra) have pilot programs, but most children are diagnosed late or after death.
- Consanguinity rate: Directly amplifies autosomal recessive disease burden. Southern India, Gujarat, Rajasthan, and Muslim communities particularly affected.
- Endogamous groups with founder mutations: Gaucher (Maharashtra, Kerala Muslims), Tay-Sachs (Gujarat), Wilson disease (all regions, higher carrier rate).
- Limited access to enzyme replacement therapy (ERT): Cost of ERT for Gaucher, Pompe, Fabry diseases is prohibitive (>INR 1 crore/year); only a minority of patients access treatment.
- Diagnostic gap: Most metabolic disorders require enzymatic assays, molecular testing, or specialized metabolite analysis - infrastructure concentrated in a few urban centers (AIIMS Delhi, CMC Vellore, KEM Mumbai, NIRRD Hyderabad).
Summary Table
| Disease | Estimated India Prevalence | Global Prevalence | Key India Features |
|---|---|---|---|
| Wilson disease | ~1 in 18,678 | 1 in 30,000-40,000 | Carrier rate 1/67; marked genetic heterogeneity |
| Gaucher disease | Most common LSD; precise incidence unknown | 1 in 40,000-60,000 | L444P predominant; Maharashtra cluster |
| Mucopolysaccharidoses | ~22% of LSDs | 1 in 25,000 (all types) | MPS I most common type |
| GM2 gangliosidoses | ~18% of LSDs (Tay-Sachs + Sandhoff) | 1 in 250,000-300,000 | Gujarat founder variant |
| Hereditary hemochromatosis | Very rare (HFE type) | 1 in 200-400 (Northern European) | C282Y allele nearly absent |
| Alpha-1 antitrypsin deficiency | Very rare | 1 in 2,000-5,000 | Z allele rare in Indian population |
| Glycogen storage diseases | ~5% of IEM | 1 in 20,000-25,000 | GSD Ia, III most common hepatic forms |
References
- Goldman-Cecil Medicine, Wilson Disease section (Epidemiology paragraph)
- Sleisenger & Fordtran's GI & Liver Disease, Ch. 77 - Inherited Metabolic Liver Disease
- Robbins & Kumar Basic Pathology, Inherited Metabolic Liver Disease summary
- Kumar M et al. (2025). The Genomic Landscape of Wilson Disease in a Pan India Disease Cohort. Mov Disord Clin Pract. PMID: 39535360
- Nagral A et al. (2023). Genomic Variations in ATP7B Gene in Indian Patients with Wilson Disease. Indian J Pediatr. PMID: 36112267
- Sheth J et al. (2024). Burden of rare genetic disorders in India: 22-year experience of a tertiary centre. Orphanet J Rare Dis. PMID: 39138584
- Lysosomal storage disorders: from biology to the clinic with reference to India - PMC
I want this Summary table in a slide
ls -la /tmp/workspace/ 2>/dev/null || mkdir -p /tmp/workspace && ls -la /tmp/workspace/
mkdir -p /tmp/workspace/imld-india && cat > /tmp/workspace/imld-india/create_slide.py << 'EOF' from pptx import Presentation from pptx.util import Inches, Pt, Emu from pptx.dml.color import RGBColor from pptx.enum.text import PP_ALIGN, MSO_ANCHOR from pptx.oxml.ns import qn from lxml import etree # ── Colour palette ────────────────────────────────────────────────────────── DARK_BLUE = RGBColor(0x0D, 0x2B, 0x4F) # title bar / header MID_BLUE = RGBColor(0x1A, 0x55, 0x8A) # col-header text LIGHT_BLUE = RGBColor(0xD6, 0xE8, 0xF7) # odd rows WHITE = RGBColor(0xFF, 0xFF, 0xFF) AMBER = RGBColor(0xE6, 0x7E, 0x22) # accent stripe GREY_TEXT = RGBColor(0x2E, 0x2E, 0x2E) COL_HDR_BG = RGBColor(0x1A, 0x55, 0x8A) COL_HDR_FG = RGBColor(0xFF, 0xFF, 0xFF) # ── Data ───────────────────────────────────────────────────────────────────── headers = ["Disease", "India Prevalence", "Global Prevalence", "Key India Features"] rows = [ ["Wilson Disease", "~1 in 18,678\n(carrier 1 in 67)", "1 in 30,000–40,000\n(carrier 1 in 90–180)", "Higher than global; marked genetic heterogeneity; no single predominant mutation"], ["Gaucher Disease", "Most common LSD;\n~16% of all LSD cases", "1 in 40,000–60,000", "L444P predominant; Maharashtra & Kerala-Muslim clusters; Type III common"], ["Mucopolysaccharidoses", "~22% of all LSDs\nin India", "1 in 25,000 (all types)", "MPS I most common type; founder variants in Indian cohorts"], ["GM2 Gangliosidoses\n(Tay-Sachs + Sandhoff)", "~18% of LSDs in India\n(Tay-Sachs 10%,\nSandhoff 7.8%)", "1 in 250,000–300,000", "Gujarat founder variant (Tay-Sachs); neurodegenerative + hepatomegaly"], ["Hereditary\nHemochromatosis", "Very rare\n(HFE-type)", "1 in 200–400\n(N. European)", "C282Y allele nearly absent in Indians; non-HFE iron overload more relevant"], ["Alpha-1 Antitrypsin\nDeficiency", "Very rare", "1 in 2,000–5,000\n(N. European)", "Z allele rare; chronically underdiagnosed; rare case reports only"], ["Glycogen Storage\nDiseases", "~5% of IEM in India;\nprecise incidence unknown", "1 in 20,000–25,000", "GSD Ia & III most common hepatic forms; consanguinity raises risk"], ] # ── Slide setup ────────────────────────────────────────────────────────────── prs = Presentation() prs.slide_width = Inches(13.333) prs.slide_height = Inches(7.5) slide = prs.slides.add_slide(prs.slide_layouts[6]) # blank # ── Background ─────────────────────────────────────────────────────────────── def solid_bg(slide, hex_color): background = slide.background fill = background.fill fill.solid() fill.fore_color.rgb = hex_color solid_bg(slide, RGBColor(0xF4, 0xF8, 0xFD)) # ── Title bar ──────────────────────────────────────────────────────────────── bar = slide.shapes.add_shape( 1, # MSO_SHAPE_TYPE.RECTANGLE Inches(0), Inches(0), Inches(13.333), Inches(1.0) ) bar.fill.solid(); bar.fill.fore_color.rgb = DARK_BLUE bar.line.fill.background() tb = slide.shapes.add_textbox(Inches(0.25), Inches(0.08), Inches(10), Inches(0.84)) tf = tb.text_frame; tf.word_wrap = False tf.margin_left = tf.margin_right = tf.margin_top = tf.margin_bottom = 0 p = tf.paragraphs[0] p.alignment = PP_ALIGN.LEFT run = p.add_run() run.text = "Inherited Metabolic Liver Diseases – Epidemiology in India" run.font.name = "Calibri" run.font.size = Pt(22) run.font.bold = True run.font.color.rgb = WHITE # Sub-title right side tb2 = slide.shapes.add_textbox(Inches(10.3), Inches(0.28), Inches(2.8), Inches(0.55)) tf2 = tb2.text_frame tf2.margin_left = tf2.margin_right = tf2.margin_top = tf2.margin_bottom = 0 p2 = tf2.paragraphs[0]; p2.alignment = PP_ALIGN.RIGHT r2 = p2.add_run() r2.text = "Summary Comparison Table" r2.font.name = "Calibri"; r2.font.size = Pt(11); r2.font.italic = True r2.font.color.rgb = RGBColor(0xAA, 0xCC, 0xEE) # ── Amber accent stripe (thin) ─────────────────────────────────────────────── stripe = slide.shapes.add_shape( 1, Inches(0), Inches(1.0), Inches(13.333), Inches(0.06) ) stripe.fill.solid(); stripe.fill.fore_color.rgb = AMBER stripe.line.fill.background() # ── Table geometry ──────────────────────────────────────────────────────────── TABLE_LEFT = Inches(0.25) TABLE_TOP = Inches(1.12) TABLE_WIDTH = Inches(12.83) TABLE_HEIGHT = Inches(6.1) col_widths = [Inches(2.0), Inches(2.4), Inches(2.5), Inches(5.93)] row_heights = [Inches(0.52)] + [Inches(0.80)] * len(rows) n_rows = 1 + len(rows) n_cols = 4 tbl = slide.shapes.add_table(n_rows, n_cols, TABLE_LEFT, TABLE_TOP, TABLE_WIDTH, TABLE_HEIGHT).table # Set column widths for ci, w in enumerate(col_widths): tbl.columns[ci].width = w # Set row heights for ri, h in enumerate(row_heights): tbl.rows[ri].height = h # ── Helper to style a cell ──────────────────────────────────────────────────── def style_cell(cell, text, font_size, bold, fg_color, bg_color, align=PP_ALIGN.CENTER, italic=False): cell.fill.solid() cell.fill.fore_color.rgb = bg_color tf = cell.text_frame tf.word_wrap = True tf.margin_left = Inches(0.06) tf.margin_right = Inches(0.06) tf.margin_top = Inches(0.04) tf.margin_bottom = Inches(0.04) tf.vertical_anchor = MSO_ANCHOR.MIDDLE # Clear existing paragraphs for para in tf.paragraphs[1:]: p_elem = para._p p_elem.getparent().remove(p_elem) lines = text.split('\n') for i, line in enumerate(lines): if i == 0: p = tf.paragraphs[0] else: p = tf.add_paragraph() p.alignment = align run = p.add_run() run.text = line run.font.name = "Calibri" run.font.size = Pt(font_size) run.font.bold = bold run.font.italic = italic run.font.color.rgb = fg_color # ── Column headers ──────────────────────────────────────────────────────────── for ci, h in enumerate(headers): style_cell(tbl.cell(0, ci), h, font_size=12, bold=True, fg_color=COL_HDR_FG, bg_color=COL_HDR_BG, align=PP_ALIGN.CENTER) # ── Data rows ───────────────────────────────────────────────────────────────── for ri, row in enumerate(rows): bg = LIGHT_BLUE if ri % 2 == 0 else WHITE for ci, text in enumerate(row): align = PP_ALIGN.LEFT if ci in (0, 3) else PP_ALIGN.CENTER bold = (ci == 0) style_cell(tbl.cell(ri + 1, ci), text, font_size=10, bold=bold, fg_color=GREY_TEXT, bg_color=bg, align=align) # ── Footer ──────────────────────────────────────────────────────────────────── ft_bar = slide.shapes.add_shape( 1, Inches(0), Inches(7.22), Inches(13.333), Inches(0.28) ) ft_bar.fill.solid(); ft_bar.fill.fore_color.rgb = DARK_BLUE ft_bar.line.fill.background() ft_tb = slide.shapes.add_textbox(Inches(0.25), Inches(7.23), Inches(13.0), Inches(0.26)) ft_tf = ft_tb.text_frame ft_tf.margin_left = ft_tf.margin_right = ft_tf.margin_top = ft_tf.margin_bottom = 0 fp = ft_tf.paragraphs[0]; fp.alignment = PP_ALIGN.LEFT fr = fp.add_run() fr.text = ("Sources: Goldman-Cecil Medicine | Sleisenger & Fordtran | Robbins Pathology | " "Kumar et al. 2025 (PMID 39535360) | Sheth et al. 2024 (PMID 39138584) | " "PMC10305895 (LSDs India)") fr.font.name = "Calibri"; fr.font.size = Pt(7.5); fr.font.color.rgb = RGBColor(0xBB, 0xCC, 0xDD) # ── Save ────────────────────────────────────────────────────────────────────── out = "/tmp/workspace/imld-india/IMLD_India_Epidemiology.pptx" prs.save(out) print("Saved:", out) EOF python /tmp/workspace/imld-india/create_slide.py
IMLD India Epidemiology
Presentation · PPTX
- Dark navy title bar with the full title and "Summary Comparison Table" label
- Amber accent stripe below the title
- 4-column table covering all 7 diseases with alternating light-blue and white row shading
- Bold blue column headers (Disease / India Prevalence / Global Prevalence / Key India Features)
- Source footer citing all references at the bottom